The discovery of novel and potent indazole NLRP3 inhibitors enabled by DNA-encoded library screening
- 28 February 2024
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 102, 129675
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Discovery of Highly Potent and BMPR2-Selective Kinase Inhibitors Using DNA-Encoded Chemical Library ScreeningJournal of Medicinal Chemistry, 2023
- Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasomeEuropean Journal of Pharmacology, 2022
- NLRP3 and pyroptosis blockers for treating inflammatory diseasesTrends in Pharmacological Sciences, 2022
- NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigmaJournal of Leukocyte Biology, 2020
- Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseasesEuropean Journal of Medicinal Chemistry, 2020
- CAPS and NLRP3Journal of Clinical Immunology, 2019
- Why Decreasing Lipophilicity Alone Is Often Not a Reliable Strategy for Extending IV Half-lifeACS Medicinal Chemistry Letters, 2018
- Large-Scale Validation of Mixed-Solvent Simulations to Assess Hotspots at Protein–Protein Interaction InterfacesJournal of Chemical Information and Modeling, 2018
- Strategy for Extending Half-life in Drug Design and Its SignificanceACS Medicinal Chemistry Letters, 2018
- On the Role of the Crystal Environment in Determining Protein Side-chain ConformationsJournal of Molecular Biology, 2002